Centro de Investigaciones Biológicas (CSIC) and CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Antimicrob Agents Chemother. 2012 Nov;56(11):5534-40. doi: 10.1128/AAC.01470-12. Epub 2012 Aug 13.
The emergence of Streptococcus pneumoniae strains displaying high levels of multidrug resistance is of great concern worldwide and a serious threat for the outcome of the infection. Modifications of the bacterial envelope by antibiotics may assist the recognition and clearance of the pathogen by the host immune system. Recognition of S. pneumoniae resistant strains by the complement component C3b was increased in the presence of specific anti-pneumococcal antibodies and subinhibitory concentrations of different macrolides and β-lactam antibiotics for all the strains investigated. However, C3b levels were unchanged in the presence of serum containing specific antibodies and sub-MICs of levofloxacin. To investigate whether LytA, the main cell wall hydrolase of S. pneumoniae, might be involved in this process, lytA-deficient mutants were constructed. In the presence of antibiotics, loss of LytA was not associated with enhanced C3b deposition on the pneumococcal surface, which confirms the importance of LytA in this interaction. The results of this study offer new insights into the development of novel therapeutic strategies using certain antibiotics by increasing the efficacy of the host immune response to efficiently recognize pneumococcal resistant strains.
具有高水平多药耐药性的肺炎链球菌菌株的出现引起了全球的极大关注,是感染结局的严重威胁。抗生素对细菌包膜的修饰可能有助于宿主免疫系统识别和清除病原体。在存在针对肺炎链球菌的特异性抗体和亚抑菌浓度的不同大环内酯类和β-内酰胺类抗生素的情况下,所有研究菌株对补体成分 C3b 的识别均增加。然而,在含有针对特定抗体和左氧氟沙星亚 MIC 的血清存在的情况下,C3b 水平不变。为了研究肺炎链球菌主要细胞壁水解酶 LytA 是否可能参与该过程,构建了 lytA 缺陷突变体。在抗生素存在的情况下,LytA 的缺失与 C3b 在肺炎链球菌表面的沉积增加无关,这证实了 LytA 在这种相互作用中的重要性。这项研究的结果为通过增加宿主免疫反应对肺炎链球菌耐药株的有效识别来提高某些抗生素治疗效果的新型治疗策略的发展提供了新的见解。